Chiesi Group

The climate crisis is a health crisis, and one of the defining conversations in respiratory care, as reflected at ERS 2026. Climate change is worsening respiratory disease and the burden is not felt equally. The most vulnerable communities breathe dirtier air, face longer allergy seasons and often lack access to early diagnosis, meaning symptoms go undetected and conditions deteriorate. At Chiesi, we believe that protecting people’s health also means protecting the environment they live in. That is why we’re committed to Net Zero by 2035, 15 years ahead of the European Climate Neutrality target, with these targets validated by the Science Based Targets Initiative (SBTi).

Over the past days at ERS 2026 in Barcelona, we’ve had the opportunity to connect with healthcare professionals, researchers, patient organisations and partners from around the world at ERS 2026. During discussions on asthma, COPD, bronchiectasis, interstitial lung diseases and sustainable respiratory care, one message stood out: improving respiratory health requires continued collaboration and innovation to create better outcomes for patients. Thank you to everyone who engaged with us, challenged our thinking and shared their perspectives. While ERS 2026 has come to an end, the conversations and learnings will continue to inspire our work in respiratory health.

Patient perspectives were at the heart of ERS 2026, and this year’s theme of “United for better breathing” spoke to the commitment we all have to ordinary people, whose lives we positively impact through advances in science across respiratory health and care. This responsibility also means not passing the burden of change onto the people at the other end of it. As a CDP 2025 Climate A List organisation, Chiesi is committed to Net Zero by 2035, 15 years ahead of the European Climate Neutrality target, with these targets validated by Science Based Targets Initiative (SBTi).

A clear takeaway from ERS 2026 was the vital role the healthcare industry has to play in climate change. In the case of inhalers, propellants are our single largest source of greenhouse gas emissions. But changing them is our biggest lever. That's why Chiesi is transitioning to a next-generation, low global warming potential, non-PFAS propellant. This reduces the carbon footprint of its pMDIs by up to 90%, bringing them in line with DPI products.

ERS 2026 brought into focus the vital role the healthcare industry has to play in climate change. In the case of inhalers, propellants are our single largest source of greenhouse gas emissions. But changing them is our biggest lever. That's why Chiesi is transitioning to a next-generation, low global warming potential, non-PFAS propellant. This reduces the carbon footprint of its pMDIs by up to 90%, bringing them in line with DPI products.

Patient perspectives are central to ERS 2026, and this year's theme of “United for better breathing” speaks to the commitment we all have to ordinary people, whose lives we positively impact through advances in science across respiratory health and care. This responsibility also means not passing the burden of change onto the people at the other end of it. As a CDP 2025 Climate A List organisation, Chiesi is committed to Net Zero by 2035, 15 years ahead of the European Climate Neutrality target, with these targets validated by Science Based Targets Initiative (SBTi).